Biological considerations and clinical applications of new HER2-targeted agents.
about
Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.Current progress of RNA aptamer-based therapeutics.Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer.Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Biological considerations and clinical applications of new HER2-targeted agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biological considerations and clinical applications of new HER2-targeted agents.
@en
Biological considerations and clinical applications of new HER2-targeted agents.
@nl
type
label
Biological considerations and clinical applications of new HER2-targeted agents.
@en
Biological considerations and clinical applications of new HER2-targeted agents.
@nl
prefLabel
Biological considerations and clinical applications of new HER2-targeted agents.
@en
Biological considerations and clinical applications of new HER2-targeted agents.
@nl
P2093
P2860
P356
P1476
Biological considerations and clinical applications of new HER2-targeted agents.
@en
P2093
Gerald M Higa
Jame Abraham
Vikramjit Singh
P2860
P304
P356
10.1586/ERA.10.129
P577
2010-09-01T00:00:00Z